Thomas J. Wilson - Apr 21, 2025 Form 4 Insider Report for ALLSTATE CORP (ALL)

Signature
/s/ Thomas J. Wilson
Stock symbol
ALL
Transactions as of
Apr 21, 2025
Transactions value $
-$5,986,848
Form type
4
Date filed
4/23/2025, 04:47 PM
Previous filing
Mar 26, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALL Common Stock Sale -$787K -4.19K -13.3% $187.82 27.3K Apr 21, 2025 By TJW Options LLC 2014 Series F1, F2
transaction ALL Common Stock Sale -$1.03M -5.47K -20.03% $189.03 21.8K Apr 21, 2025 By TJW Options LLC 2014 Series F1, F3
transaction ALL Common Stock Sale -$1.84M -9.72K -44.49% $189.67 12.1K Apr 21, 2025 By TJW Options LLC 2014 Series F1, F4
transaction ALL Common Stock Sale -$941K -4.93K -40.64% $190.93 7.2K Apr 21, 2025 By TJW Options LLC 2014 Series F1, F5
transaction ALL Common Stock Sale -$1.34M -6.95K -96.62% $191.99 243 Apr 21, 2025 By TJW Options LLC 2014 Series F1, F6
transaction ALL Common Stock Sale -$46.9K -243 -100% $192.83 0 Apr 21, 2025 By TJW Options LLC 2014 Series F1, F7
holding ALL Common Stock 229K Apr 21, 2025 Direct F8
holding ALL Common Stock 111K Apr 21, 2025 By 2023-B GRAT
holding ALL Common Stock 65.3K Apr 21, 2025 By 2024-C GRAT
holding ALL Common Stock 69.8K Apr 21, 2025 By 2025-A GRAT
holding ALL Common Stock 7.58K Apr 21, 2025 By 401(k) Plan
holding ALL Common Stock 274K Apr 21, 2025 By 2020 GRAT Remainder Trust
holding ALL Common Stock 258K Apr 21, 2025 Remainder GRAT
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted on August 22, 2024.
F2 Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $187.350 to $188.285. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
F3 Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $188.390 to $189.335. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
F4 Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $189.390 to $190.340. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
F5 Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $190.560 to $191.540. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
F6 Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $191.630 to $192.585. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
F7 Reflects weighted average sale price for open-market sales transactions reported herein. Actual sales prices ranged from $192.725 to $192.990. The reporting person provided to the issuer, and will provide to any security holder of The Allstate Corporation or member of the SEC staff, full information regarding the number of shares sold at each separate price upon request.
F8 Balance also reflects 16.167 shares acquired during the period of January 3, 2025 through April 2, 2025, through the Shareowner Service Plus Plan, which reinvests dividends paid on The Allstate Corporation common shares.